Почетна › Рак простате › Kanzas
Kliničke studije za Рак простате u državi Kanzas
21 studija za Рак простате traži učesnike na lokacijama u državi Kanzas.
Gradovi u državi Kanzas
- Kansas City12 студија
- Topeka7 студија
- Overland Park6 студија
- Olathe5 студија
- Lawrence3 студија
- Pittsburg3 студија
- Wichita3 студија
Zvanični tekst studije (na engleskom)
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
- Central Care Cancer Center - Garden City, Garden City
- Mercy Hospital Pittsburg, Pittsburg
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 13. 11. 2026. · NCT04423211Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- и још 4
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 12. 11. 2026. · NCT03866382Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
- Kansas University Cancer Center, Kansas City
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 5. 11. 2026. · NCT07745361Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Central Care Cancer Center - Garden City, Garden City
- Central Care Cancer Center - Great Bend, Great Bend
- Veteran Administration Eastern Kansas Healthcare, Leavenworth
- и још 4
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 40 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT05334069Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
- University of Kansas Cancer Center, Kansas City
- The University of Kansas Cancer Center - Olathe, Olathe
- University of Kansas Hospital-Indian Creek Campus, Overland Park
- и још 2
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 3. 11. 2026. · NCT06632977Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
- HaysMed, Hays
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- и још 4
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 3. 11. 2026. · NCT06931340A Study of [225Ac]Ac-AKY-2519 in Patients With Metastatic Castration-Resistant Prostate Cancer
- University of Kansas Medical Center, Kansas City
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 2. 11. 2026. · NCT07581184Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Lawrence Memorial Hospital, Lawrence
- The University of Kansas Cancer Center - Olathe, Olathe
- и још 3
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 23. 10. 2026. · NCT05946213A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
- University of Kansas Medical Center, Westwood
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 20. 10. 2026. · NCT07213674Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC
- University of Kansas Hospital, Kansas City
Тражи се учесникФаза 3
Узраст од 18 до 100 · Мушкарци · Ажурирано 15. 10. 2026. · NCT06855277Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- University of Kansas Cancer Center, Kansas City
- Olathe Health Cancer Center, Olathe
- University of Kansas Cancer Center-Overland Park, Overland Park
- и још 1
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 8. 10. 2026. · NCT03678025DESTINY-PANTUMOUR04
- Research Site, Topeka
Тражи се учесникОпсервациона студија
Узраст од 18 до 130 · Оба пола · Ажурирано 25. 9. 2026. · NCT07124000Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
- University of Kansas Hospital, Kansas City
Тражи се учесникФаза 2/3
Узраст од 18 до 100 · Мушкарци · Ажурирано 22. 9. 2026. · NCT06780670Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
- Wichita Urology Group, Wichita
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 11. 9. 2026. · NCT06056830PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.
- University of Kansas Medical Center, Kansas City
Тражи се учесникФаза 3
Узраст 18 и старији · Мушкарци · Ажурирано 22. 7. 2026. · NCT06274047HoLEP Prior to Radiation Therapy for Patients With LUTS/Retention and Concurrent Prostate Cancer
- University of Kansas Health System, Kansas City
Тражи се учесник
Узраст 18 и старији · Оба пола · Ажурирано 13. 7. 2026. · NCT03802851Integrated Cancer Repository for Cancer Research
- Saint Luke's Cancer Instititute - South, Overland Park
Тражи се учесникОпсервациона студијаЗдраве особе су добродошле
Узраст од 19 до 110 · Оба пола · Ажурирано 29. 6. 2026. · NCT02012699TERPS Trial for de Novo Oligometastic Prostate Cancer
- KU Medical Center- Cancer Center, Kansas City
Тражи се учесникФаза 2
Узраст 18 и старији · Мушкарци · Ажурирано 3. 6. 2026. · NCT05223803Study of AZD0754 in Participants With Metastatic Prostate Cancer
- Research Site, Westwood
Тражи се учесникФаза 1/2
Узраст од 18 до 130 · Мушкарци · Ажурирано 23. 2. 2026. · NCT06267729A Safety and Dose-finding Study of PRL-02 Depot in Men With Advanced Prostate Cancer
- Wichita Urology Group, Wichita
Тражи се учесникФаза 1
Узраст 18 и старији · Мушкарци · Ажурирано 4. 2. 2026. · NCT04729114Vitamin D for Prostate Endocrine Therapy
- University of Kansas Cancer Center, Kansas City
- University of Kansas Cancer Center-Overland Park, Overland Park
- University of Kansas Health System Saint Francis Campus, Topeka
- и још 1
Тражи се учесникФаза 3
Узраст 50 и старији · Мушкарци · Ажурирано 15. 1. 2026. · NCT05838716Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.